Deep Track Capital, LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:44 am Sale |
2024-09-30 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 1,000,000 1.970% |
-1,184,440 (-54.22%) |
Filing |
| 2024-02-14 08:56 am Purchase |
2023-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 2,184,440 6.030% |
1,894,118 (+652.42%) |
Filing |
| 2023-06-30 4:00 pm Purchase |
2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 290,322 9.990% |
290,322 (New Position) |
Filing |